Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. China Cancer Drugs Market


6. Market Share – China Oncology Drugs Market

6.1 By Therapy
6.2 By Indication
6.3 By Drugs


7. Therapy– China Oncology Drugs Market

7.1 Chemotherapy
7.2 Targeted Therapy
7.3 Immunotherapy (Biologic Therapy)
7.4 Hormonal Therapy


8. Indication– China Oncology Drugs Market

8.1 Blood Cancer
8.2 Breast Cancer
8.3 Gastrointestinal Cancer
8.4 Prostate Cancer
8.5 Lung Cancer
8.6 Skin Cancer
8.7 Ovarian Cancer
8.8 Cervical Cancer
8.9 Kidney Cancer
8.11 Other Cancers


9. Drugs– China Oncology Drugs Market

9.1 ESAs (Erythropoiesis Stimulating Agents)
9.2 G-CSFs (Granulocyte-colony Stimulating Factors)
9.3 Anti-emetics
9.4 Bisphosphonates
9.5 Opioids
9.6 NSAIDs & Others


10. Porters Five Forces

10.1 Overview
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Degree of Competition
10.5 Threat of New Entrants
10.6 Threat of Substitutes


11. Company Analysis

11.1 Bristol Myers Squibb

11.1.1 Overview
11.1.2 Recent Development
11.1.3 Revenue Analysis

11.2 Merc

11.2.1 Overview
11.2.2 Recent Development
11.2.3 Revenue Analysis

11.3 Eli Lilly

11.3.1 Overview
11.3.2 Recent Development
11.3.3 Revenue Analysis

11.4 Sino BioPharma

11.4.1 Overvie
11.4.2 Recent Development
11.4.3 Revenue Analysis

11.5 F Hoffmann-La Roche A

11.5.1 Overview
11.5.2 Recent Development
11.5.3 Revenue Analysis

11.6 Johnson & Johnson

11.6.1 Overview
11.6.2 Recent Development
11.6.3 Revenue Analysis

11.7 AbbVie Inc.

11.7.1 Overview
11.7.2 Recent Development
11.7.3 Revenue Analysis

11.8 AstraZeneca plc

11.8.1 Overview
11.8.2 Recent Development
11.8.3 Revenue Analysis



List of Figures

Figure-01: China Cancer Drugs Market (Billion US$), 2018 – 2021
Figure-02: Forecast for – China Cancer Drugs Market (Billion US$), 2022 – 2027
Figure-03: Therapy – Chemotherapy Market (Billion US$), 2018 – 2021
Figure-04: Therapy – Forecast for Chemotherapy Market (Billion US$), 2022 – 2027
Figure-05: Therapy – Targeted Therapy Market (Billion US$), 2018 – 2021
Figure-06: Therapy – Forecast for Targeted Therapy Market (Billion US$), 2022 – 2027
Figure-07: Therapy – Immunotherapy (Biologic Therapy) Market (Billion US$), 2018 – 2021
Figure-08: Therapy – Forecast for Immunotherapy (Biologic Therapy) Market (Billion US$), 2022 – 2027
Figure-09: Therapy – Hormonal Therapy Market (Billion US$), 2018 – 2021
Figure-10: Therapy – Forecast for Hormonal Therapy Market (Billion US$), 2022 – 2027
Figure-11: Indication – Blood Cancer Market (Billion US$), 2018 – 2021
Figure-12: Indication – Forecast for Blood Cancer Market (Billion US$), 2022 – 2027
Figure-13: Indication – Breast Cancer Market (Billion US$), 2018 – 2021
Figure-14: Indication – Forecast for Breast Cancer Market (Billion US$), 2022 – 2027
Figure-15: Indication – Gastrointestinal Cancer Market (Billion US$), 2018 – 2021
Figure-16: Indication – Forecast for Gastrointestinal Cancer Market (Billion US$), 2022 – 2027
Figure-17: Indication – Prostate Cancer Market (Billion US$), 2018 – 2021
Figure-18: Indication – Forecast for Prostate Cancer Market (Billion US$), 2022 – 2027
Figure-19: Indication – Lung Cancer Market (Billion US$), 2018 – 2021
Figure-20: Indication – Forecast for Lung Cancer Market (Billion US$), 2022 – 2027
Figure-21: Indication – Skin Cancer Market (Billion US$), 2018 – 2021
Figure-22: Indication – Forecast for Skin Cancer Market (Billion US$), 2022 – 2027
Figure-23: Indication – Ovarian Cancer Market (Billion US$), 2018 – 2021
Figure-24: Indication – Forecast for Ovarian Cancer Market (Billion US$), 2022 – 2027
Figure-25: Indication – Cervical Cancer Market (Million US$), 2018 – 2021
Figure-26: Indication – Forecast for Cervical Cancer Market (Million US$), 2022 – 2027
Figure-27: Indication – Kidney Cancer Market (Billion US$), 2018 – 2021
Figure-28: Indication – Forecast for Kidney Cancer Market (Billion US$), 2022 – 2027
Figure-29: Indication – Other Cancers Market (Billion US$), 2018 – 2021
Figure-30: Indication – Forecast for Other Cancers Market (Billion US$), 2022 – 2027
Figure-31: Drugs – ESAs (Erythropoiesis Stimulating Agents) Market (Billion US$), 2018 – 2021
Figure-32: Drugs – Forecast for ESAs (Erythropoiesis Stimulating Agents) Market (Billion US$), 2022 – 2027
Figure-33: Drugs – G-CSFs (Granulocyte-colony Stimulating Factors) Market (Billion US$), 2018 – 2021
Figure-34: Drugs – Forecast for G-CSFs (Granulocyte-colony Stimulating Factors) Market (Billion US$), 2022 – 2027
Figure-35: Drugs – Anti-emetics (Billion US$), 2018 – 2021
Figure-36: Drugs – Forecast for Anti-emetics (Billion US$), 2022 – 2027
Figure-37: Drugs – Bisphosphonates (Billion US$), 2018 – 2021
Figure-38: Drugs – Forecast for Bisphosphonates (Billion US$), 2022 – 2027
Figure-39: Drugs – Opioids (Billion US$), 2018 – 2021
Figure-40: Drugs – Forecast for Opioids (Billion US$), 2022 – 2027
Figure-41: Drugs – NSAIDs & Others (Billion US$), 2018 – 2021
Figure-42: Drugs – Forecast for NSAIDs & Others (Billion US$), 2022 – 2027
Figure-43: Bristol Myers Squibb – Global Revenue (Billion US$), 2018 – 2021
Figure-44: Bristol Myers Squibb – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-45: Merck – Global Revenue (Billion US$), 2018 – 2021
Figure-46: Merck – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-47: Eli Lilly – Global Revenue (Billion US$), 2018 – 2021
Figure-48: Eli Lilly – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-49: Sino BioPharma – Global Revenue (Billion US$), 2018 – 2021
Figure-50: Sino BioPharma – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-51: F Hoffmann-La Roche AG – Global Revenue (Billion US$), 2018 – 2021
Figure-52: F Hoffmann-La Roche AG – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-53: Johnson & Johnson – Global Revenue (Billion US$), 2018 – 2021
Figure-54: Johnson & Johnson – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-55: AbbVie Inc. – Global Revenue (Billion US$), 2018 – 2021
Figure-56: AbbVie Inc. – Forecast for Global Revenue (Billion US$), 2022 – 2027
Figure-57: AstraZeneca plc – Global Revenue (Billion US$), 2018 – 2021
Figure-58: AstraZeneca plc – Forecast for Global Revenue (Billion US$), 2022 – 2027

List of Tables

Table-01: China Cancer Drugs Market Share by Therapy (Percent), 2018 – 2021
Table-02: Forecast for – China Cancer Drugs Market Share by Therapy (Percent), 2022 – 2027
Table-03: China Cancer Drugs Market Share by Indication (Percent), 2018 – 2021
Table-04: Forecast for – China Cancer Drugs Market Share by Indication (Percent), 2022 – 2027
Table-05: China Cancer Drugs Market Share by Drugs (Percent), 2018 – 2021
Table-06: Forecast for – China Cancer Drugs Market Share by Drugs (Percent), 2022 – 2027